Early Use of Novel Biologics in Psoriatic Arthritis: An Evolving Standard of Care

Axial manifestations are common in patients with PsA. How can we use the latest data on inhibition of IL-17A and IL-23 to better manage axial symptoms?

Vinod Chandran, MBBS, MD, DM, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: January 11, 2021 Expired: January 10, 2022

Hear expert insights on when to use interleukin inhibitors in the course of psoriatic arthritis.

Vinod Chandran, MBBS, MD, DM, PhD Alexis Ogdie, MD, MSCE Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: December 29, 2020 Expired: December 28, 2021

Guidelines and Therapies

Head-to-Head Studies

Review key data on when to use interleukin inhibitors in the course of psoriatic arthritis.

Vinod Chandran, MBBS, MD, DM, PhD Alexis Ogdie, MD, MSCE Released: December 29, 2020